A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma

Condition:   Asthma
Interventions:   Drug: Sirukumab;   Drug: Placebo;   Drug: Rescue medication
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified June 2016

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.